ARID1A and neoplasm: Although the top mutated genes such as TTN, TP53, MUC16, ARID1A, and LRP1B were identical between the two subgroups, the tumor mutation burden (TMB) was significantly higher in the OMIRPS‐low subgroup and the TMB was negatively correlated with the OMIRPS score.